The Efficacy of Topical Mesalazine Sustained-Release Tablets in Crohn's Disease Patients With Oral Ulcer

• Status: Unknown status
• Trial end date: 2017-01-01
• Target enrollment: 0
• Participant gender: All

Summary

This study aims at evaluating efficacy and safety of topical using Mesalazine Sustained-Release Tablets in in the treatment of oral ulcers in patients with Crohn's disease.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Xijing Hospital of Digestive Diseases
• Treatments: Flavin Mononucleotide; Mesalamine; Riboflavin

Criteria

Inclusion Criteria:

• Age between 18~65, both gender.

• Patients with oral ulcer and confirmed Crohn's disease.

Exclusion Criteria:

• Contraindications to study drugs.

• Underwent or will accept oral Surgery.

• Patients are not able to sign the informed consent or not comply with the study protocol.

• Planning for pregnancy, pregnancy and lactating women.

• Enrolled in other clinical trials in the past 30 days.

• Patients with concurrent / new other serious diseases will affect the effectiveness and safety evaluation.